Zhejiang Hisun Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000013Z2
CNY
11.55
-0.07 (-0.6%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
10,488.60
9,734.09
10,330.06
11,929.39
12,085.02
11,311.27
10,980.12
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
10,488.60
9,734.09
10,330.06
11,929.39
12,085.02
11,311.27
10,980.12
Raw Material Cost
6,225.44
5,937.90
6,682.66
7,501.87
7,608.11
6,774.41
6,636.13
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
104.91
155.61
218.26
288.68
348.15
425.08
531.33
Selling and Distribution Expenses
2,660.28
2,664.56
2,892.91
3,031.87
3,169.57
3,076.41
3,693.48
Other Expenses
29.68
11.46
7.63
3.76
-6.23
-8.44
27.99
Total Expenditure (Excl Depreciation)
9,287.46
8,872.68
9,870.17
10,860.01
11,063.50
10,191.51
11,140.86
Operating Profit (PBDIT) excl Other Income
1201.1
861.4
459.90000000000003
1069.4
1021.5
1119.8
-160.7
Other Income
66.41
279.23
140.23
316.39
265.98
382.70
2,655.37
Operating Profit (PBDIT)
2,146.34
2,093.66
1,480.58
2,307.25
2,070.77
2,234.68
3,056.42
Interest
104.91
155.61
218.26
288.68
348.15
425.08
531.33
Exceptional Items
-223.65
-141.26
-240.25
-137.62
-48.35
9.25
-1,136.27
Gross Profit (PBDT)
4,263.16
3,796.19
3,647.40
4,427.52
4,476.91
4,536.86
4,343.99
Depreciation
976.23
1,083.92
1,044.57
1,039.97
954.33
881.03
888.30
Profit Before Tax
841.55
712.87
-22.49
840.98
719.94
937.82
500.51
Tax
267.89
126.76
14.15
192.00
133.56
180.97
183.83
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
540.71
601.18
-93.17
489.05
486.89
417.19
93.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
540.71
601.18
-93.17
489.05
486.89
417.19
93.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.78
-9.87
-3.84
2.37
23.74
305.97
230.19
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
547.49
591.31
-97.01
491.42
510.63
723.17
323.27
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
8,607.25
8,341.35
8,101.97
8,079.09
7,303.28
6,678.67
6,274.22
Earnings per share (EPS)
0.47
0.52
-0.08
0.42
0.43
0.43
0.1
Diluted Earnings per share
0.47
0.52
-0.08
0.42
0.43
0.43
0.1
Operating Profit Margin (Excl OI)
10.52%
7.5%
2.86%
7.97%
7.04%
8.58%
-4.44%
Gross Profit Margin
17.33%
18.46%
9.89%
15.77%
13.85%
16.08%
12.65%
PAT Margin
5.16%
6.18%
-0.9%
4.1%
4.03%
3.69%
0.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 7.75% vs -5.77% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -7.41% vs 709.59% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 14.63% vs 35.36% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -32.58% vs -28.72% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Zhejiang Hisun Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
10,488.60
0
10,488.60
Other Operating Income
0.00
0.00
0.00
Total Operating income
10,488.60
0
10,488.60
Raw Material Cost
6,225.44
0
6,225.44
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
104.91
0
104.91
Selling and Distribution Expenses
2,660.28
0
2,660.28
Other Expenses
29.68
0.00
29.68
Total Expenditure (Excl Depreciation)
9,287.46
0
9,287.46
Operating Profit (PBDIT) excl Other Income
1,201.14
0.00
1,201.14
Other Income
66.41
0
66.41
Operating Profit (PBDIT)
2,146.34
0
2,146.34
Interest
104.91
0
104.91
Exceptional Items
-223.65
0
-223.65
Gross Profit (PBDT)
4,263.16
0
4,263.16
Depreciation
976.23
0
976.23
Profit Before Tax
841.55
0
841.55
Tax
267.89
0
267.89
Provisions and contingencies
0
0
0.00
Profit After Tax
540.71
0
540.71
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
540.71
0
540.71
Share in Profit of Associates
0
0
0.00
Minority Interest
6.78
0
6.78
Other related items
0.00
0.00
0.00
Consolidated Net Profit
547.49
0
547.49
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,607.25
0
8,607.25
Earnings per share (EPS)
0.47
0
0.47
Diluted Earnings per share
0.47
0
0.47
Operating Profit Margin (Excl OI)
10.52%
0%
0.00
10.52%
Gross Profit Margin
17.33%
0%
0.00
17.33%
PAT Margin
5.16%
0%
0.00
5.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,048.86 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 7.75% vs -5.77% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 54.75 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -7.41% vs 709.59% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 207.99 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 14.63% vs 35.36% in Dec 2024

Annual - Interest
Interest 10.49 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -32.58% vs -28.72% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.52%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024